PRODUCT DESIGN CONFUSION

PRODUCT DESIGN CONFUSION was reported 103 times

PRODUCT DESIGN CONFUSION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 alpha-1 Adrenergic Agonist [EPC] 2 0.0005
1 Calcitonin [EPC] 1 0.0003
2 Antihypoglycemic Agent [EPC] 1 0.0002
3 Sigma-1 Agonist [EPC] 1 0.0001
4 Antifibrinolytic Agent [EPC] 1 0.0001
5 Catecholamine [EPC] 4 0.0000
6 GLP-1 Receptor Agonist [EPC] 18 0.0000
7 PCSK9 Inhibitor [EPC] 1 0.0000
8 Radiographic Contrast Agent [EPC] 1 0.0000
9 Leukotriene Receptor Antagonist [EPC] 1 0.0000
10 B Lymphocyte Stimulator-specific Inhibitor [EPC] 1 0.0000
11 Cardiac Glycoside [EPC] 2 0.0000
12 General Anesthetic [EPC] 1 0.0000
13 beta3-Adrenergic Agonist [EPC] 1 0.0000
14 Glycopeptide Antibacterial [EPC] 1 0.0000
15 Histamine-2 Receptor Antagonist [EPC] 2 0.0000
16 Serotonin-3 Receptor Antagonist [EPC] 2 0.0000
17 Androgen Receptor Inhibitor [EPC] 1 0.0000
18 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
19 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
20 Osmotic Laxative [EPC] 3 0.0000
21 Expectorant [EPC] 2 0.0000
22 Interleukin-23 Antagonist [EPC] 1 0.0000
23 Prostacycline Vasodilator [EPC] 1 0.0000
24 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
25 alpha-Adrenergic Blocker [EPC] 1 0.0000
26 Estrogen [EPC] 1 0.0000
27 Interferon beta [EPC] 1 0.0000
28 Proton Pump Inhibitor [EPC] 2 0.0000
29 Vitamin D [EPC] 1 0.0000
30 Corticosteroid [EPC] 4 0.0000
31 Vitamin B12 [EPC] 1 0.0000
32 Vitamin C [EPC] 1 0.0000
33 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
34 Insulin Analog [EPC] 1 0.0000
35 Atypical Antipsychotic [EPC] 1 0.0000
36 Tumor Necrosis Factor Blocker [EPC] 1 0.0000